Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of the proprietary medicinal products is substantial. |
Clinical Added Value
| minor |
BUCCOLAM offers a level IV improvement in actual benefit in the management of prolonged acute convulsive seizures in children and adolescents suffering from epilepsy in view of its buccal administration and presentation in ready-to-use syringe form. |
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
F1FKebrLEANbXEDK
Listen
